SPOTLIGHT -
Slideshow
Author(s):
Up to 50% of cases of cannabis-induced psychosis covert to schizophrenia. A new study provides striking evidence for abuse of other substances and schizophrenia onset.
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Treating ‘Morally Objectionable’ Patients
The Slow Road to Psychosis
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia